CRC - California Resources Corp
LONG BEACH, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) plans to release its second quarter 2026 financial results on Monday, August 10th before market hours.
LONG BEACH, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (the “Company”) announced today the pricing of its private offering of $550 million in aggregate principal amount of its 7.250% senior unsecured notes due 2035 (the “Notes”) at par.
LONG BEACH, Calif., June 16, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (the “Company”) announced today that, subject to market and other conditions, it intends to offer and sell to eligible purchasers $550 million in aggregate principal amount of senior unsecured notes due 2035 (the “Notes”).
California Resources stands to benefit from regulatory compromise enabling thousands of new wells in Kern County while tightening offshore restrictions. CRC's merger with Berry Corporation enhances operational efficiency. Emerging discussion around using carbon capture to unlock unconventional oil in-state signals potential for future production expansion.
California Resources (CRC) reported earnings 30 days ago. What's next for the stock?
Energy sector consolidation has accelerated through 2026 so far, with majors and large independents acquiring scale, inventory, and strategic infrastructure.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
[url="]Pfizer Inc. [/url](NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 B
Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR Newswire BURLINGTON,
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that calderasib (MK-1084), an investigational oral specific KRAS G12C inhibi
CRC announces California's first operational carbon capture project, advancing large-scale CO2 storage and expanding the state's climate strategy.
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that its FDA-approved Shield⢠blood test is now included in updated Ameri
KERN COUNTY, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) has achieved the first landmark carbon dioxide (CO2) injection at Carbon TerraVault I (CTV I), a first-of-its-kind carbon capture and storage (CCS) project that will help advance California's progress toward carbon neutrality.
KERN COUNTY, Calif. , May 26, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) has achieved the first landmark carbon dioxide (CO2) injection at Carbon TerraVault I (CTV I), a first-of-its-kind carbon capture and storage (CCS) project that will help advance California's progress toward carbon neutrality.
Here is how California Resources Corporation (CRC) and ConocoPhillips (COP) have performed compared to their sector so far this year.
CRC beat Q1 adjusted EPS and revenues on strong oil pricing, even as a massive derivative mark-to-market loss pushed GAAP results into the red.
California Resources NYSE: CRC reported a stronger-than-expected first quarter and raised its 2026 outlook, citing higher oil prices, improved capital efficiency, accelerated drilling plans and additional cost savings from its Berry merger.
- Positive data announced from Phase 1 Dose Expansion Study of varsetatug masetecan (“Varseta-M”) EpCAM PROBODY® ADC in Patients with Advanced Colorectal Cancer (CRC) - - Enrollment of 40 patients in Varseta-M Dose Optimization completed; data update expected in 2H 2026 to inform monotherapy dose selection and potential registrational trial in late line CRC - - Varseta-M Phase 1 study evaluating combination with bevacizumab is ongoing with initial data expected by 1H 2027; Phase 1/2 Varseta-M chemotherapy combination study to be initiated in 2H 2026 - - Initiation of Phase 1 expansion cohort(s) in non-CRC indications planned for 2H 2026 - - Company to host conference call today at 5 p.m. ET / 2 p.m.
California Resources Corporation (CRC) Q1 2026 Earnings Call Transcript